vs
Astrana Health, Inc.（ASTH）与Western Midstream Partners, LP（WES）财务数据对比。点击上方公司名可切换其他公司
Western Midstream Partners, LP的季度营收约是Astrana Health, Inc.的1.1倍（$1.0B vs $950.5M），Western Midstream Partners, LP净利率更高（18.5% vs 0.7%，领先17.8%），Astrana Health, Inc.同比增速更快（42.9% vs 11.0%），Western Midstream Partners, LP自由现金流更多（$335.4M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 7.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Sunoco LP是在美国特拉华州注册的业主有限合伙企业，总部位于得克萨斯州达拉斯，历史可追溯至1886年。公司已从垂直一体化能源企业转型为燃料分销商及能源基础设施运营商，此前经营的油气勘探开采、炼油、化工生产、燃油零售等业务均已完成剥离。
ASTH vs WES — 直观对比
营收规模更大
WES
是对方的1.1倍
$950.5M
营收增速更快
ASTH
高出31.9%
11.0%
净利率更高
WES
高出17.8%
0.7%
自由现金流更多
WES
多$341.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.0B |
| 净利润 | $6.6M | $190.7M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 29.7% |
| 净利率 | 0.7% | 18.5% |
| 营收同比 | 42.9% | 11.0% |
| 净利润同比 | 184.4% | -42.8% |
| 每股收益（稀释后） | $0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHWES
| Q4 25 | $950.5M | $1.0B | ||
| Q3 25 | $956.0M | $952.3M | ||
| Q2 25 | $654.8M | $942.1M | ||
| Q1 25 | $620.4M | $916.9M | ||
| Q4 24 | $665.2M | $928.4M | ||
| Q3 24 | $478.7M | $883.1M | ||
| Q2 24 | $486.3M | $905.4M | ||
| Q1 24 | $404.4M | $887.3M |
净利润ASTHWES
| Q4 25 | $6.6M | $190.7M | ||
| Q3 25 | $373.0K | $339.6M | ||
| Q2 25 | $9.4M | $341.7M | ||
| Q1 25 | $6.7M | $309.0M | ||
| Q4 24 | $-7.8M | $333.6M | ||
| Q3 24 | $16.1M | $288.5M | ||
| Q2 24 | $19.2M | $378.6M | ||
| Q1 24 | $14.8M | $572.8M |
营业利润率ASTHWES
| Q4 25 | 1.9% | 29.7% | ||
| Q3 25 | 2.0% | 46.4% | ||
| Q2 25 | 3.1% | 47.2% | ||
| Q1 25 | 3.3% | 44.7% | ||
| Q4 24 | 0.1% | 45.9% | ||
| Q3 24 | 5.9% | 44.8% | ||
| Q2 24 | 6.2% | 51.9% | ||
| Q1 24 | 7.5% | 76.6% |
净利率ASTHWES
| Q4 25 | 0.7% | 18.5% | ||
| Q3 25 | 0.0% | 35.7% | ||
| Q2 25 | 1.4% | 36.3% | ||
| Q1 25 | 1.1% | 33.7% | ||
| Q4 24 | -1.2% | 35.9% | ||
| Q3 24 | 3.4% | 32.7% | ||
| Q2 24 | 3.9% | 41.8% | ||
| Q1 24 | 3.7% | 64.6% |
每股收益（稀释后）ASTHWES
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $819.5M |
| 总债务越低越好 | — | $8.2B |
| 股东权益账面价值 | $779.3M | — |
| 总资产 | $2.2B | $15.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHWES
| Q4 25 | $429.5M | $819.5M | ||
| Q3 25 | $463.4M | $177.3M | ||
| Q2 25 | $342.1M | $129.7M | ||
| Q1 25 | $260.9M | $448.4M | ||
| Q4 24 | $290.8M | $1.1B | ||
| Q3 24 | $350.3M | $1.1B | ||
| Q2 24 | $327.7M | $344.1M | ||
| Q1 24 | $337.3M | $295.2M |
总债务ASTHWES
| Q4 25 | — | $8.2B | ||
| Q3 25 | — | $6.9B | ||
| Q2 25 | — | $6.9B | ||
| Q1 25 | — | $6.9B | ||
| Q4 24 | — | $6.9B | ||
| Q3 24 | — | $6.9B | ||
| Q2 24 | — | $7.1B | ||
| Q1 24 | — | $7.3B |
股东权益ASTHWES
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | — | ||
| Q2 25 | $765.5M | — | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | — | ||
| Q2 24 | $678.9M | — | ||
| Q1 24 | $653.5M | — |
总资产ASTHWES
| Q4 25 | $2.2B | $15.0B | ||
| Q3 25 | $2.2B | $12.1B | ||
| Q2 25 | $1.4B | $12.2B | ||
| Q1 25 | $1.3B | $12.5B | ||
| Q4 24 | $1.4B | $13.1B | ||
| Q3 24 | $1.3B | $13.0B | ||
| Q2 24 | $1.3B | $12.2B | ||
| Q1 24 | $1.2B | $12.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $557.6M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $335.4M |
| 自由现金流率自由现金流/营收 | -0.6% | 32.6% |
| 资本支出强度资本支出/营收 | 0.3% | 21.6% |
| 现金转化率经营现金流/净利润 | -0.44× | 2.92× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $1.5B |
8季度趋势，按日历期对齐
经营现金流ASTHWES
| Q4 25 | $-2.9M | $557.6M | ||
| Q3 25 | $10.0M | $570.2M | ||
| Q2 25 | $90.9M | $564.0M | ||
| Q1 25 | $16.6M | $530.8M | ||
| Q4 24 | $-10.9M | $554.4M | ||
| Q3 24 | $34.0M | $551.3M | ||
| Q2 24 | $23.2M | $631.4M | ||
| Q1 24 | $6.0M | $399.7M |
自由现金流ASTHWES
| Q4 25 | $-6.0M | $335.4M | ||
| Q3 25 | $7.4M | $385.5M | ||
| Q2 25 | $89.5M | $385.4M | ||
| Q1 25 | $13.6M | $388.4M | ||
| Q4 24 | $-13.5M | $315.7M | ||
| Q3 24 | $31.7M | $361.9M | ||
| Q2 24 | $20.4M | $419.6M | ||
| Q1 24 | $5.6M | $205.9M |
自由现金流率ASTHWES
| Q4 25 | -0.6% | 32.6% | ||
| Q3 25 | 0.8% | 40.5% | ||
| Q2 25 | 13.7% | 40.9% | ||
| Q1 25 | 2.2% | 42.4% | ||
| Q4 24 | -2.0% | 34.0% | ||
| Q3 24 | 6.6% | 41.0% | ||
| Q2 24 | 4.2% | 46.3% | ||
| Q1 24 | 1.4% | 23.2% |
资本支出强度ASTHWES
| Q4 25 | 0.3% | 21.6% | ||
| Q3 25 | 0.3% | 19.4% | ||
| Q2 25 | 0.2% | 19.0% | ||
| Q1 25 | 0.5% | 15.5% | ||
| Q4 24 | 0.4% | 25.7% | ||
| Q3 24 | 0.5% | 21.5% | ||
| Q2 24 | 0.6% | 23.4% | ||
| Q1 24 | 0.1% | 21.8% |
现金转化率ASTHWES
| Q4 25 | -0.44× | 2.92× | ||
| Q3 25 | 26.69× | 1.68× | ||
| Q2 25 | 9.65× | 1.65× | ||
| Q1 25 | 2.48× | 1.72× | ||
| Q4 24 | — | 1.66× | ||
| Q3 24 | 2.11× | 1.91× | ||
| Q2 24 | 1.21× | 1.67× | ||
| Q1 24 | 0.40× | 0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
WES
暂无分部数据
